T2 Biosystems Inc Entrate Y/Y
Cos'è Entrate Y/Y di T2 Biosystems Inc?
Entrate Y/Y di T2 Biosystems Inc è -45.74%
Qual è la definizione di Entrate Y/Y?
La crescita annuale dei ricavi degli ultimi 3 anni è la crescita dei ricavi da un anno all'altro in media negli ultimi 3 anni.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Entrate Y/Y di aziende nel Health Care settore su NASDAQ rispetto a T2 Biosystems Inc
Cosa fa T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Aziende con entrate y/y simili a T2 Biosystems Inc
- China International Development ha Entrate Y/Y di -45.93%
- Twintek Investment ha Entrate Y/Y di -45.87%
- Sinopharm Co ha Entrate Y/Y di -45.85%
- Sinopharm Co ha Entrate Y/Y di -45.85%
- Alector ha Entrate Y/Y di -45.84%
- e Gorgé SA ha Entrate Y/Y di -45.81%
- T2 Biosystems Inc ha Entrate Y/Y di -45.74%
- Dynavax Technologies ha Entrate Y/Y di -45.65%
- Evolution Petroleum ha Entrate Y/Y di -45.64%
- China SXT Pharmaceuticals Inc ha Entrate Y/Y di -45.53%
- Contel Technology ha Entrate Y/Y di -45.53%
- Hazer ha Entrate Y/Y di -45.49%
- 8K Miles Software Services ha Entrate Y/Y di -45.45%